# Daniël Blockmans

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/daniel-blockmans/

## Facts

| Field | Value |
| --- | --- |
| Citations | 16,897 |
| Field | Vasculitis and related conditions |
| h-index | 58 |
| i10-index | 154 |
| Last Known Institution | KU Leuven |
| OpenAlex ID | https://openalex.org/A5083643588 |
| ORCID iD | https://orcid.org/0000-0001-9783-1780 |
| Works | 364 |

## Researcher papers

- [Trial of Tocilizumab in Giant-Cell Arteritis](https://scholariq.org/papers/trial-of-tocilizumab-in-giant-cell-arteritis/)
- [Immunosuppressive therapy in lupus nephritis: The Euro‐Lupus Nephritis Trial, a randomized trial of low‐dose versus high‐dose intravenous cyclophosphamide](https://scholariq.org/papers/immunosuppressive-therapy-in-lupus-nephritis-the-euro-lupus-nephritis-trial-a/)
- [EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update](https://scholariq.org/papers/eular-recommendations-for-the-management-of-anca-associated-vasculitis-2022/)
- [Revised 2017 international consensus on testing of ANCAs in granulomatosis with polyangiitis and microscopic polyangiitis](https://scholariq.org/papers/revised-2017-international-consensus-on-testing-of-ancas-in-granulomatosis-with/)
- [Pulse versus daily oral cyclophosphamide for induction of remission in ANCA-associated vasculitis: long-term follow-up](https://scholariq.org/papers/pulse-versus-daily-oral-cyclophosphamide-for-induction-of-remission-in-anca/)
- [Mycophenolate mofetil versus cyclophosphamide for remission induction in ANCA-associated vasculitis: a randomised, non-inferiority trial](https://scholariq.org/papers/mycophenolate-mofetil-versus-cyclophosphamide-for-remission-induction-in-anca/)
- [Antineutrophil cytoplasmic antibody-associated vasculitides and IgG4-related disease: A new overlap syndrome](https://scholariq.org/papers/antineutrophil-cytoplasmic-antibody-associated-vasculitides-and-igg4-related/)

## Researcher topics

- [Vasculitis and related conditions](https://scholariq.org/topics/vasculitis-and-related-conditions-2/)
- [Systemic Sclerosis and Related Diseases](https://scholariq.org/topics/systemic-sclerosis-and-related-diseases/)
- [Otitis Media and Relapsing Polychondritis](https://scholariq.org/topics/otitis-media-and-relapsing-polychondritis/)
- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)
- [Sarcoidosis and Beryllium Toxicity Research](https://scholariq.org/topics/sarcoidosis-and-beryllium-toxicity-research/)

## Researcher university

- [KU Leuven](https://scholariq.org/institutions/ku-leuven/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.